University of California, San Francisco
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, San Francisco sits in the top decile of US sponsors by registered trial count (#10 of 15,742 sponsors by registered trial count).
University of California, San Francisco: 1,713 sponsored US clinical trials, 272 recruiting.
University of California, San Francisco sponsors 1,713 registered US clinical trials on ClinicalTrials.gov, 272 of them currently recruiting, and 1,130 completed. 196 of these trials are in Phase 3-4 (later-stage) and 359 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 18 trials.
Top-decile sponsor footprint
University of California, San Francisco ranks in the top decile of sponsors by registered trial count (#10 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,130 of 1,305 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,713 total, page 26 of 35
Motivational Interviewing to Reduce Substance Use Among Depression Patients
NCT02420561
Adult Study Oxytocin - Behavioral
NCT02567032
Endothelial Function and Arterio-Venous Fistula Maturation
NCT01604473
Abiraterone Post Ketoconazole for Prostate Cancer
NCT01199146
Study Targeting Affect Regulation
NCT01237366
Computer-Based Balance Training for People With Parkinson's Disease
NCT01162226
A Study of PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma
NCT01227434
Monitoring Exhaled Propofol to Individualize General Anesthesia
NCT01191021
Adherence, Improvement Measure (AIM) System
NCT01252212
Adult Oxytocin Study
NCT02577575
Impact of Anesthetic Choice (Sevoflurane Versus Desflurane) on Airway Reflex Recovery in the Context of Antagonized Neuromuscular Block
NCT01199237
Irrigation Versus no Irrigation for Cutaneous Abscess
NCT01606657
Comparison of Three Methods of Hemoglobin Monitoring
NCT01284296
Safety Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Tumors of the Brain
NCT01116661
Hematopoietic Stem Cell Transplantation (HSCT) for Children With SCID Utilizing Alemtuzumab, Plerixafor & Filgrastim
NCT01182675
Nab-paclitaxel (Abraxane), Gemcitabine, and Capecitabine (Xeloda) for Pancreatic Adenocarcinoma
NCT01161186
Support From Hospital to Home for Elders: A Randomized Controlled Study
NCT01221532
Pedometers to Assess and Increase Physical Activity Among Children With Chronic Kidney Disease
NCT01270529
Topical Radial Artery Vasodilation
NCT01155167
Metabolic Impact of Fructose Restriction in Obese Children
NCT01200043
Early Aggressive Correction of Severe Acidosis With Tris-hydroxymethylaminomethane (THAM)
NCT01326260
Mesalamine to Reduce T Cell Activation in HIV Infection
NCT01090102
Safety and Efficacy Study of Combination Treatment With Excimer Laser, Clobex Spray, and Vectical Ointment in the Treatment of Psoriasis
NCT01012713
Effect of Obesity on Long-term Clinical Outcomes After Kidney Donation
NCT01368822
Depression Management Project
NCT01150604
Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial
NCT00991029
Maintaining Nonsmoking
NCT01162239
Treating Major Depression With Yoga: A Prospective, Randomized Controlled Pilot Trial
NCT01210651
The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo
NCT00997035
Single-incision Laparoscopic (SILS) Versus Conventional Laparoscopic Appendectomy for the Treatment of Acute Appendicitis
NCT00997516
A Study Evaluating Gemcitabine Plus Bosutinib for Patients With Resected Pancreatic Cancer
NCT01025570
Yttrium-90 Radioembolization With Glass Microspheres (TheraSphere) for Patients With Hepatocellular Carcinoma
NCT01290523
The Effects of the Rivastigmine Patch on Parkinson's Disease With Memory and/or Thinking Problems
NCT00988117
Caries Management by Risk Assessment in Children
NCT01310283
Topiramate Treatment of Alcohol Use Disorders in Veterans With Post Traumatic Stress Disorder (PTSD): A Pilot Controlled Trial of Augmentation Therapy
NCT01087736
The Role of Inflammation and Aging in HIV-Associated Cardiovascular Risk
NCT01333644
Transforming Research and Clinical Knowledge in TBI Pilot
NCT01565551
Mycotic Ulcer Treatment Trial I
NCT00996736
Music Therapy is Associated With Decreased Pain and Agitation in Intubated ICU Patients
NCT01316536
An Educational Intervention to Improve Resident Comfort With Communication at the End of Life
NCT01150968
Factors Association With Poor Physical Function in Older Adults With Schizophrenia
NCT01092598
Pharmacokinetic Study in Patients With Chronic Kidney Disease and Healthy Volunteers
NCT01087749
Stonewall Treatment Evaluation Project
NCT01129401
A Study of Neural Circuit Responses to Catechol-O-methyl Transferase (COMT) Inhibitors
NCT01158950
Pharmacokinetic Interactions Between an Herbal Medicine (African Potato) and Antiretroviral Agents (Lopinavir/Ritonavir)
NCT01227590
Health-Related Quality of Life (QOL), Physical and Respiratory Function in Patients With Myeloma Affecting the Spine
NCT01006070
Anterior Shoulder Dislocation
NCT01585467
The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease
NCT01055730
Automated Telephone Nutrition Support
NCT01040676
Effect of Genetic Variants in MATE1 and OCT3 on the Pharmacodynamics of Metformin in African Americans
NCT01681693
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 193 |
| Phase 2 | 166 |
| Phase 3 | 44 |
| Phase 4 | 152 |
Therapeutic Areas
What is open in the University of California, San Francisco pipeline
272 recruiting of 1,713 indexed (16% open); 1,130 completed (66%).
Phase mix: 196 late (III/IV) vs 359 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (18 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, San Francisco: open-pipeline peers nationwide
Peers matched on 1,713 registered trials and 16% open enrollment, not the therapeutic-area sidebar.
University of California, San Francisco sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,713 trials (± recruiting share)
- Duke University · 1,725 trials · 11% recruiting
- Stanford University · 1,744 trials · 15% recruiting
- VA Office of Research and Development · 1,668 trials · 17% recruiting
- Pfizer · 1,845 trials · 6% recruiting
Sponsors near 16% open enrollment (± trial volume)
- University of Oregon · 16% recruiting · 63 trials
- Fox Chase Cancer Center · 16% recruiting · 183 trials
- Youngstown State University · 16% recruiting · 19 trials
- ECOG-ACRIN Cancer Research Group · 16% recruiting · 75 trials
Related
What to do with this University of California, San Francisco page
1,713 registered trials is a research-attention snapshot, not an endorsement of University of California, San Francisco or any single study.
- 272 of University of California, San Francisco's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition University of California, San Francisco studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, San Francisco pipeline card: 1,713 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.